Mycophenolate mofetil in the treatment of lupus nephritis – 7 years on

1 Chan TM  Li FK  Tang CSO  . Efficacy of mycophenolate mofetil in diffuse proliferative lupus nephritis. N Engl J Med 2000; 343: 1156 – 1162 .

2 Ginzler EM  Dooley MA  Aranow C  . Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005; 353: 2219 – 2228 .

3 Ong LM  Hooi LS  Lim TO  . Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology 2005; 10: 504 – 510 .

4 Contreras G  Pardo V  Leclercq B  . Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004; 350: 971 – 980 .

5 Chan TM  Tse KC  Li FK  Tang CSO  Mok MY  . Long-term study of mycophenolate mofetil as both induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 2005; 16: 1076 – 1084 .

6 Appel GB  Dooley MA  Ginzler EM  . Mycophenolate mofetil compared with intravenous cyclophosphamide as induction therapy for lupus nephritis: Aspreva Lupus Management Study (ALMS) results. J Am Soc Nephrol 2007; 18: 47A .

7 The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group  . A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029 – 1037 .

8 Mok CC  Mak A  Chu WP  To CH  Wong SN  . Long-term survival of southern Chinese patients with systemic lupus erythematosus. Medicine 2005; 84: 218 – 224 .

9 Hu W  Liu ZH  Chen H  . Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. Chin Med J 2002; 115: 705 – 709 .

10 Cross J  Dwomoa A  Andrews P  . Mycophenolate mofetil for remission induction in severe lupus nephritis. Nephron Clin Pract 2005; 100: c92 – c100 .

11 Tse KC  Tang CSO  Lio WI  Lam MF  Chan TM  . Quality of life comparison between corticosteroid-and-mycofenolate mofetil and corticosteroid-and-oral cyclophosphamide in the treatment of severe lupus nephritis. Lupus 2006; 15: 371 – 379 .

12 Korbet SM  Schwartz MM  Evans J  Lewis EJ  . ; Collaborative Study Group.  Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol 2007; 18: 244 – 254 .

13 Cooper GS  Parks CG  Treadwell EL  . Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 2002; 11: 161 – 167 .

14 Chan TM  . Preventing renal failure in patients with severe lupus nephritis. Kidney Int 2005; 94: s116 – s119 .

15 Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria  . The American College of Rheumatology Response Criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006; 54: 421 – 432 .

16 Illei GG  Takada K  Parkin D  . Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy. Arthritis Rheum 2002; 46: 995 – 1002 .

17 Moroni G  Quaglini S  Maccario M  Banfi G  Ponticelli C  . Nephritic flares are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 1996; 50: 2047 – 2053 .

18 Wilson EC  Jayne DR  Dellow E  Fordham RJ  . The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis. Rheumatology 2007; 46: 1096 – 1101 .

19 Chan TM  Tse KC  Tang CSO  Lai KN  Li FK  . Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine. Lupus 2005; 14: 265 – 272 .

20 Houssiau FA  Vasconcelos C  D’Cruz D  . Immunosuppressive therapy in lupus nephritis: the euro-lupus nephritis trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 2002; 46: 2121 – 2131 .

21 Yung S  Tsang RC  Sun Y  Leung JK  Chan TM  . Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis. J Am Soc Nephrol 2005; 16: 3281 – 3294 .

22 Appel GB  Cameron JS  . Lupus nephritis. In: J Feehally J Floege RJ Johnson , (eds), Comprehensive Clinical Nephrology. 3rd ed. Philadelphia, USA : Mosby Elsevier ; 2007. p. 291–303.